New Initiative to Tackle Alcohol Harms Will Focus on Taxation 01/11/2022 Kerry Cullinan A $15 million initiative to address the harms of alcohol consumption through policy change was launched Tuesday, roughly doubling the total global spending on mitigating the effects of alcohol. Alcohol is one of the top-ten drivers of death, illness and injury, with wide-ranging social and economic harms, many disproportionately affecting young adults, according to Vital […] Continue reading -> TB Cases and Deaths Increase as COVID Pandemic Wipes Out Decades of Gains 27/10/2022 Kerry Cullinan Tuberculosis cases and deaths have increased for the first time in decades, and fewer cases were detected and fewer people treated during 2021 – all as a result of disruptions caused by the COVID-19 pandemic, according to the World Health Organization (WHO). An estimated 10.6 million people fell sick with TB last year, an increase […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05/10/2022 Kerry Cullinan Russia’s war in Ukraine is draining resources to build better health systems, while Sino-American rivalry is undermining the global solidarity needed to address future pandemics. But the massive under-investment in new antibiotics to combat drug-resistant “superbugs” and weak primary health systems might be the biggest enemies of global health. This was according to global health […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Posts navigation Older postsNewer posts
TB Cases and Deaths Increase as COVID Pandemic Wipes Out Decades of Gains 27/10/2022 Kerry Cullinan Tuberculosis cases and deaths have increased for the first time in decades, and fewer cases were detected and fewer people treated during 2021 – all as a result of disruptions caused by the COVID-19 pandemic, according to the World Health Organization (WHO). An estimated 10.6 million people fell sick with TB last year, an increase […] Continue reading -> WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05/10/2022 Kerry Cullinan Russia’s war in Ukraine is draining resources to build better health systems, while Sino-American rivalry is undermining the global solidarity needed to address future pandemics. But the massive under-investment in new antibiotics to combat drug-resistant “superbugs” and weak primary health systems might be the biggest enemies of global health. This was according to global health […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Posts navigation Older postsNewer posts
WHO and Civil Society Raise Alarm Over Growing Threat of Drug-Resistant Fungi to Public Health 25/10/2022 Megha Kaveri & Elaine Ruth Fletcher The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance. Meanwhile, […] Continue reading -> From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05/10/2022 Kerry Cullinan Russia’s war in Ukraine is draining resources to build better health systems, while Sino-American rivalry is undermining the global solidarity needed to address future pandemics. But the massive under-investment in new antibiotics to combat drug-resistant “superbugs” and weak primary health systems might be the biggest enemies of global health. This was according to global health […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Posts navigation Older postsNewer posts
From Bedside to Boardroom – Parliamentarians Claim their Place in Global Health Debates 20/10/2022 Elaine Ruth Fletcher BERLIN – Nearly 20 years ago, Ricardo Baptista Leite began his work as a young medical doctor in an infectious disease ward in Portugal – an experience that changed his life. “I met patients who couldn’t make it to the hospital because they couldn’t afford public transportation,” he said. “I diagnosed patients infected with multi […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05/10/2022 Kerry Cullinan Russia’s war in Ukraine is draining resources to build better health systems, while Sino-American rivalry is undermining the global solidarity needed to address future pandemics. But the massive under-investment in new antibiotics to combat drug-resistant “superbugs” and weak primary health systems might be the biggest enemies of global health. This was according to global health […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Posts navigation Older postsNewer posts
Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05/10/2022 Kerry Cullinan Russia’s war in Ukraine is draining resources to build better health systems, while Sino-American rivalry is undermining the global solidarity needed to address future pandemics. But the massive under-investment in new antibiotics to combat drug-resistant “superbugs” and weak primary health systems might be the biggest enemies of global health. This was according to global health […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Posts navigation Older postsNewer posts
WHO Advises Rationing Cholera Shots Amid Global Vaccine Shortage 19/10/2022 Megha Kaveri A shortage of cholera vaccines and a number of outbreaks have prompted the World Health Organization (WHO) to advise countries to administer single doses of the vaccine instead of the usual two doses. So far, 29 countries have reported cholera outbreaks, with Haiti, Syria and Malawi dealing with large outbreaks. The standard preventive approach to […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05/10/2022 Kerry Cullinan Russia’s war in Ukraine is draining resources to build better health systems, while Sino-American rivalry is undermining the global solidarity needed to address future pandemics. But the massive under-investment in new antibiotics to combat drug-resistant “superbugs” and weak primary health systems might be the biggest enemies of global health. This was according to global health […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Posts navigation Older postsNewer posts
A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05/10/2022 Kerry Cullinan Russia’s war in Ukraine is draining resources to build better health systems, while Sino-American rivalry is undermining the global solidarity needed to address future pandemics. But the massive under-investment in new antibiotics to combat drug-resistant “superbugs” and weak primary health systems might be the biggest enemies of global health. This was according to global health […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Posts navigation Older postsNewer posts
Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05/10/2022 Kerry Cullinan Russia’s war in Ukraine is draining resources to build better health systems, while Sino-American rivalry is undermining the global solidarity needed to address future pandemics. But the massive under-investment in new antibiotics to combat drug-resistant “superbugs” and weak primary health systems might be the biggest enemies of global health. This was according to global health […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Posts navigation Older postsNewer posts
Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05/10/2022 Kerry Cullinan Russia’s war in Ukraine is draining resources to build better health systems, while Sino-American rivalry is undermining the global solidarity needed to address future pandemics. But the massive under-investment in new antibiotics to combat drug-resistant “superbugs” and weak primary health systems might be the biggest enemies of global health. This was according to global health […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Posts navigation Older postsNewer posts
As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Posts navigation Older postsNewer posts